HomeABVC • NASDAQ
add
ABVC Biopharma Inc
Previous close
$0.91
Day range
$0.88 - $1.01
Year range
$0.40 - $1.57
Market cap
15.42M USD
Avg Volume
466.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.97K | -9.19% |
Operating expense | 381.67K | 2.15% |
Net income | 229.30K | 159.82% |
Net profit margin | 11.66K | 165.87% |
Earnings per share | — | — |
EBITDA | -369.28K | 26.60% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 313.12K | 124.51% |
Total assets | 7.54M | -3.14% |
Total liabilities | 6.82M | 4.36% |
Total equity | 723.96K | — |
Shares outstanding | 15.05M | — |
Price to book | 10.12 | — |
Return on assets | -8.63% | — |
Return on capital | -12.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 229.30K | 159.82% |
Cash from operations | -493.61K | -14.67% |
Cash from investing | — | — |
Cash from financing | 581.46K | 1,413.38% |
Net change in cash | 93.94K | 123.24% |
Free cash flow | -282.32K | 57.97% |
About
Founded
2015
Website
Employees
18
